Quantum-SI Incorporated
WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
FIGI: BBG00X8RS963
QSI
Quantum-SI Incorporated
GICS: -
·
Sektor: Healthcare
·
Sub-Sektor: Biotechnology
NAME
Quantum-SI Incorporated
ISIN
US74765K1051
TICKER
QSI
MIC
XNAS
REUTERS
QSI.OQ
BLOOMBERG
QSI US
Financial Intelligence
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Fr., 03.01.2025
Quantum-SI
US74765K1051
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 15,625,000 shares of common stock at a purchase price of $3.20 per share, pursuant to a registered d...
Quantum-SI
Fr., 20.12.2024
Quantum-SI
US74765K1051
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a new paper that was submitted to BioRxiv, demonstrating the capabilities of its proprietary bioinformatics tool called ProteoVue, for detecting and quantifying Single Amino Acid Variants (SAAVs). The paper, titled “Detect...
Quantum-SI
Mi., 18.12.2024
Quantum-SI
US74765K1051
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 46,666 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity I...
Quantum-SI
Do., 12.12.2024
Quantum-SI
US74765K1051
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announced that it has expanded its international distribution network to a total of 15 partners.
The commercial distribution network includes further expansion across Western Europe, Eastern Europe and Asia, as well as new expansion int...
Quantum-SI
Mi., 04.12.2024
Quantum-SI
US74765K1051
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has introduced the Platinum Library Prep Kit, V2, an advanced tool for single-molecule protein sequencing that is designed to simplify workflows and expand researchers’ ability to analyze the proteome.
The new kit is designed to deliver...
Quantum-SI
Di., 03.12.2024
Quantum-SI
US74765K1051
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced the launch of its protein Barcoding Kit designed to transform protein research by empowering researchers with an advanced multiplexed protein screening solution.
The protein Barcoding Kit offers a multiplexed solution for ...
Quantum-SI
Do., 21.11.2024
Quantum-SI
US74765K1051
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst event that was hosted in New York City on November 20th, 2024.
Quantum-Si’s Management team announced Platinum™ Pro, the Company’s evolution of Platinum, as well as Proteus™, t...
Quantum-SI
Mi., 20.11.2024
Quantum-SI
US74765K1051
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced technology industries. Through this collaboration, Avantor will distribute Qua...
Quantum-SI
Mi., 20.11.2024
Quantum-SI
US74765K1051
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop its new proteomics platform, Proteus™, and advance Quantum-Si’s core technologies of amino acid binders and aminopeptidases using NVIDIA AI and accelerated computing.
This collabora...
Quantum-SI
Mi., 20.11.2024
Quantum-SI
US74765K1051
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™ and SkyWaterTechnology (NASDAQ: SKYT), the trusted technology realization partner, announced today they will jointly expand their relationship to support development of Proteus™, Quantum-Si’s next-generation platform designed to transform ...
Quantum-SI
Informationen zu Product Placements
SMART * AD
P R O D U C T S U G G E S T I O N S
